Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Novo is trying to keep ahead of rival Eli Lilly, whose Mounjaro diabetes product is also expected to gain approval as a weight-loss drug.
Helve S, Helantera I, Laine M, et al
Van San, E
The GLP-1 (treatment) cohort was comprised of individuals who (i) had no prior history of GLP-1 use, (ii) initiated GLP-1 medications from January 2019 onwards with the prescription originating from a primary care provider or endocrinologist, and (iii) had medication orders indicating a minimum duration of 12 months of prescriptions
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
